EPIC-Norfolk Publications Database

Relationship of lipoprotein-associated apolipoprotein C-III with lipid variables and coronary artery disease risk: The EPIC-Norfolk prospective population study.

van Capelleveen JC, Lee SR, Verbeek R, Kastelein JJP, Wareham NJ, Stroes ESG, Hovingh GK, Khaw KT, Boekholdt SM, Witztum JL, and Tsimikas S

Journal of clinical lipidology. Mar 2018

(DOI : 10.1016/j.jacl.2018.08.010)

A 3-SNP gene risk score and a metabolic risk score both predict hypertriglyceridemia and cardiovascular disease risk.

Verbeek R, Oldoni F, Surendran RP, Zwinderman AH, Khaw KT, Stroes ESG, Wareham NJ, Boekholdt SM, and Dallinga-Thie GM

Journal of clinical lipidology. Jan 2018

(DOI : 10.1016/j.jacl.2019.02.005)

Effect of Long-Term Low Lipoproteins on Neurocognitive Function.

Verbeek R, Boekholdt SM, Luben R, Stroes ESG, Khaw KT, and Hovingh GK

Journal of the American College of Cardiology. Nov 2017

(DOI : 10.1016/j.jacc.2018.06.043)

Cardiovascular disease risk associated with elevated lipoprotein(a) attenuates at low low-density lipoprotein cholesterol levels in a primary prevention setting.

Verbeek R, Hoogeveen RM, Langsted A, Stiekema LCA, Verweij SL, Hovingh GK, Wareham NJ, Khaw KT, Boekholdt SM, Nordestgaard BG, and Stroes ESG

European heart journal. Oct 2017

(DOI : 10.1093/eurheartj/ehy334)

Ideal cardiovascular health influences cardiovascular disease risk associated with high lipoprotein(a) levels and genotype: The EPIC-Norfolk prospective population study.

Perrot N, Verbeek R, Sandhu M, Boekholdt SM, Hovingh GK, Wareham NJ, Khaw KT, and Arsenault BJ

Atherosclerosis. Jul 2016

(DOI : 10.1016/j.atherosclerosis.2016.11.010)

Carriers of the PCSK9 R46L Variant Are Characterized by an Antiatherogenic Lipoprotein Profile Assessed by Nuclear Magnetic Resonance Spectroscopy-Brief Report.

Verbeek R, Boyer M, Boekholdt SM, Hovingh GK, Kastelein JJ, Wareham N, Khaw KT, and Arsenault BJ

Arteriosclerosis, thrombosis, and vascular biology. Jun 2016

(DOI : 10.1161/ATVBAHA.116.307995)

Lipoprotein(a) Improves Cardiovascular Risk Prediction Based on Established Risk Algorithms.

Verbeek R, Sandhu MS, Hovingh GK, Sjouke B, Wareham NJ, Zwinderman AH, Kastelein JJP, Khaw KT, Tsimikas S, and Boekholdt SM

Journal of the American College of Cardiology. Jun 2016

(DOI : 10.1016/j.jacc.2017.01.017)

Population and assay thresholds for the predictive value of lipoprotein (a) for coronary artery disease: the EPIC-Norfolk Prospective Population Study.

Verbeek R, Boekholdt SM, Stoekenbroek RM, Hovingh GK, Witztum JL, Wareham NJ, Sandhu MS, Khaw KT, and Tsimikas S

Journal of lipid research. Jan 2016

(DOI : S0022-2275(20)35424-9)